Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter to the Editor
  • Published:

Impact of a dedicated post-transplant vaccination service at an Australian cancer centre

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

References

  1. Rubin LG, Levin MJ, Ljungman P, Davies EG, Avery R, Tomblyn M et al. 2013 IDSA clinical practice guideline for vaccination of the immunocompromised host. Clin Infect Dis 2013; 58: e44–e100.

    Article  Google Scholar 

  2. Shigayeva A, Rudnick W, Green K, Chen DK, Demczuk W, Gold WL et al. Invasive pneumococcal disease among immunocompromised persons: implications for vaccination programs. Clin Infect Dis 2016; 62: 139–147.

    Article  Google Scholar 

  3. Teh BW, Harrison SJ, Pellegrini M, Thursky KA, Worth LJ, Slavin MA . Changing treatment paradigms for patients with plasma cell myeloma: impact upon immune determinants of infection. Blood Rev 2014; 28: 75–86.

    Article  Google Scholar 

  4. Tomblyn M, Chiller T, Einsele H, Gress R, Sepkowitz K, Storek J et al. Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspective. Biol Blood Marrow Transplant 2009; 15: 1143–1238.

    Article  CAS  Google Scholar 

  5. Ariza-Heredia EJ, Gulbis AM, Stolar KR, Kebriaei P, Shah DP, McConn KK et al. Vaccination guidelines after hematopoietic stem cell transplantation: practitioners' knowledge, attitudes, and gap between guidelines and clinical practice. Transplant Infect Dis 2014; 16: 878–886.

    Article  CAS  Google Scholar 

  6. Kumar D, Humar A, Plevneshi A, Siegal D, Franke N, Green K et al. Invasive pneumococcal disease in adult hematopoietic stem cell transplant recipients: a decade of prospective population-based surveillance. Bone Marrow Transplant 2008; 41: 743–747.

    Article  CAS  Google Scholar 

  7. Australian Technical Advisory Group on Immunisation (ATAGI). The Australian Immunisation Handbook, 10th edn. Australian Government Department of Health: Canberra, Australia, 2013.

  8. Australian Technical Advisory Group on Immunisation (ATAGI). The Australian Immunisation Handbook, 9th edn. Australian Government Department of Health: Canberra, Australia, 2008.

  9. Miller PDE, de Silva TI, Skinner R, Gilleece M, Peniket A, Hamblin A et al. Routine vaccination practice after adult and paediatric allogeneic haematopoietic stem cell transplant: a survey of UK NHS programmes. Bone Marrow Transplant 2017; 52: 775–777.

    Article  CAS  Google Scholar 

  10. Zwar N, Hasan I, Harris M, Traynor V . Barriers and facilitators to influenza vaccination among high-risk groups aged less than 65 years-views from general practitioners and practice nurses. Aust N Z J Public Health 2007; 31: 558–561.

    Article  Google Scholar 

  11. Lerchenfeldt SM, Cronin SM, Chandrasekar PH . Vaccination adherence in hematopoietic stem cell transplant patients: a pilot study on the impact of vaccination cards and reminder telephone calls. Transplant Infect Dis 2013; 15: 634–638.

    Article  CAS  Google Scholar 

  12. Meiring J, de Silva TI, Snowden JA . A study of adherence to a vaccination schedule following adult allogeneic haematopoietic stem cell transplants in UK transplant centre. Bone Marrow Transplant 2015; 50 (Suppl 1): s203–s204.

    Google Scholar 

  13. Dombkowski KJ, Cowan AE, Reeves SL, Foley MR, Dempsey AF . The impacts of email reminder/recall on adolescent influenza vaccination. Vaccine 2017; 35: 3089–3095.

    Article  Google Scholar 

  14. Doherty M, Schmidt-Ott R, Santos JI, Stanberry LR, Hofstetter AM, Rosenthal SL et al. Vaccination of special populations: protecting the vulnerable. Vaccine 2016; 34: 6681–6690.

    Article  Google Scholar 

Download references

Acknowledgements

BWT is kindly supported by the Peter MacCallum Cancer Centre Clinical Research fellowship.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to B W Teh.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Teh, B., Joyce, T., Slavin, M. et al. Impact of a dedicated post-transplant vaccination service at an Australian cancer centre. Bone Marrow Transplant 52, 1681–1683 (2017). https://doi.org/10.1038/bmt.2017.195

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/bmt.2017.195

Search

Quick links